Mendota Financial Group LLC Decreases Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Mendota Financial Group LLC lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 26.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 515 shares of the medical research company’s stock after selling 181 shares during the period. Mendota Financial Group LLC’s holdings in Agilent Technologies were worth $76,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in A. Vanguard Group Inc. grew its position in Agilent Technologies by 18.2% in the first quarter. Vanguard Group Inc. now owns 29,884,345 shares of the medical research company’s stock valued at $4,348,471,000 after acquiring an additional 4,605,228 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Agilent Technologies by 13.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,542,054 shares of the medical research company’s stock valued at $1,242,956,000 after purchasing an additional 1,042,926 shares in the last quarter. Massachusetts Financial Services Co. MA increased its stake in Agilent Technologies by 5.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company’s stock worth $1,952,832,000 after buying an additional 809,149 shares during the period. Champlain Investment Partners LLC acquired a new position in Agilent Technologies in the 1st quarter worth $61,218,000. Finally, Marshall Wace LLP boosted its position in Agilent Technologies by 48.6% in the 2nd quarter. Marshall Wace LLP now owns 957,128 shares of the medical research company’s stock valued at $124,073,000 after buying an additional 313,155 shares during the last quarter.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the sale, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at approximately $3,650,640. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,953 shares of company stock worth $2,013,630.

Agilent Technologies Stock Up 0.8 %

Shares of Agilent Technologies stock opened at $143.82 on Friday. The stock has a market capitalization of $41.32 billion, a price-to-earnings ratio of 29.84, a PEG ratio of 6.96 and a beta of 1.05. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The business’s 50 day simple moving average is $140.51 and its 200-day simple moving average is $138.97.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the company earned $1.43 earnings per share. The firm’s revenue for the quarter was down 5.6% on a year-over-year basis. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be given a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is 19.50%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on A shares. Evercore ISI lifted their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. UBS Group upped their target price on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Bank of America raised their price target on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Barclays upped their price target on shares of Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a report on Friday, August 23rd. Finally, TD Cowen raised their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $143.64.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.